Playback speed
10 seconds
NCCN Guidelines Update for ER+ Breast Cancer: CDK4/6 and PIK3CA Inhibitors for Advanced BC & Tamoxifen and Aromatase Inhibitors for Early BC
9,350 views
September 13, 2019
Login to view comments.
Click here to Login